The Hunt for the Next 10 Bagger

[triptrade]

IHSN ready to blow Huge news released after market close yesterday just the start of things to come
No dillution moves big
Outstanding Shares: 1,420,608,702
Authorized Shares: 1,500,000,000
Float: 502,061,566
Verified by:
Holladay Stock Transfer
[phone]
2939 N67th PL Ste C
Scottsdale, AZ 85251

Per http://www.otcmarkets.com/stock/IHSN/financials Apr. 6th Attorney letter with respect to current information of shares shown above 1,192,670,870 are restricted and can’t be sold. A lot of strong hands holding shares here.

Plus just released their new line of kitchen products already being sold under the Yaku name starting with the Yaku Grill https://www.theyakugrill.com/flare/next already ordered mine should add nicely to the financials for the Christmas season
http://finance.yahoo.com/news/Innovative-Health-Sciences-to-iw-3092605317.html?x=0&.v=1

With numerous other products on the way it’s a no brainer to get in at these levels but always do your own DD

With Forbes Riley on board were almost guaranteed multi millions in sales http://www.forbesriley.com/

Innovative Health Sciences Unveils Name of Its First Fitness Product "The Forbes Riley CrossToner"

Industry Award Winner Forbes Riley to Shoot TV Infomercial in November 2010

CLEARWATER, FL, Oct 20, 2010 (MARKETWIRE via COMTEX) -- Innovative Health Sciences, Inc. (PINKSHEETS: IHSN) announced today that it is pleased to officially unveil the brand name of its first fitness product, the Forbes Riley CrossToner(R) ("CrossToner"). Per prior announcements, the Company has obtained the global rights to market a revolutionary fitness product designed for women to tone the arms, shoulders, and inner and outer thighs. The Company is scheduled to begin shooting a direct response television commercial staring Forbes Riley and the CrossToner beginning the week of November 8, 2010. The commercial will be tested nationally in select markets following the Christmas in the first quarter of the year, the prime selling season for fitness products.
"Recently, at the annual conference for our industry, the Electronic Retailing Association, Forbes was presented with top honors, winning three awards for Best Female Presenter, the Best Live Shopping On-Air Guest and the Best Long Form Commercial for Housewares. We now have even more of a reason to be excited with her involvement in marketing the CrossToner. We are excited capitalize on her outstanding contributions in the direct response industry, as well as capture her enthusiasm and knowledge of the CrossToner on film," said Chris Winter, President of the Innovative Health Sciences.
Forbes Riley commented, "I am thrilled to be associated with the CrossToner, and back this product 100% with the use of my name. The CrossToner is very effective at sculpting the major muscle groups women are most concerned about, and it never gets boring. I can't wait to discuss the details and demonstrate how and why the CrossToner is go great. So stay tuned for the infomercial coming out next year!"
About Innovative Health Sciences, Inc. Innovative Health Sciences, Inc. remains focused on its plan of acquiring companies that are leaders in their respective market niches and have the potential for additional upside. Acquired in 2010, Harrington Multi Media Marketing (HM3) is a leading producer of infomercials and short-form direct television spots and developer of Internet-based marketing campaigns and transactional websites. HM3 also offers complete turnkey solutions to launch new consumer products including: assistance with outsourcing products and prototype development; set-up and management of call centers; product fulfillment and customer service; credit card processing; purchasing and management of media outlets, including telephone sales, direct response television (DRTV), and Internet sales. For more information, please visit www.ihs-development.com or call 727-230-1036 ex. 157.
This press release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company to be materially different from the statements made herein. Statements contained in this news release, other than those identifying historical facts, constitute "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934 and the Safe Harbor provisions as contained in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relating to the Company's future expectations, including but not limited to revenues and earnings, technology efficacy, strategies and plans, are subject to safe harbors protection. Actual Company results and performance may be materially different from any future results, performance, strategies, plans, or achievements that may be expressed or implied by any such forward-looking statements. The Company disclaims any obligation to update or revise any forward-looking statements
Contact:
Innovative Health Sciences, Inc.
Chris Winter
President
Tel: [phone] #157